Journal ID (nlm-ta): Cancer Res
Journal ID (iso-abbrev): Cancer Res
Title:
Cancer Research
Publisher:
American Association for Cancer Research
ISSN
(Print):
0008-5472
ISSN
(Electronic):
1538-7445
Publication date
(Print):
15
April
2022
Publication date
(Electronic):
21
February
2022
Volume: 82
Issue: 8
Pages: 1448-1460
Affiliations
[1
]Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
[2
]Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University,
Portland, Oregon.
[3
]Department of Medicine, University of California, San Francisco, San Francisco, California.
[4
]Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,
San Francisco, California.
[5
]Department of Cellular and Molecular Pharmacology, University of California, San Francisco,
San Francisco, California.
[6
]Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
[7
]Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo
Clinic, Rochester, Minnesota.
[8
]Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis,
Minnesota.
[9
]Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer
Center, Buffalo, New York.
[10
]Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California.
[11
]Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los
Angeles, California.
[12
]Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.
[13
]Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
[14
]Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New
York City, New York.
[15
]Howard Hughes Medical Institute, Chevy Chase, Maryland.
[16
]Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham,
Alabama.
Author notes
[#]
J.W. Tyner, F. Haderk, A. Kumaraswamy, L.B. Baughn, B. Van Ness, S. Liu, and H. Marathe
contributed equally to this article.
[*
]
Corresponding Author: Jeffrey W. Tyner, Division of Hematology and Medical Oncology, Knight Cancer Institute,
Department of Cell, Development and Cancer Biology, Oregon Health & Science University,
3181 SW Sam Jackson Park Road, Portland, OR 97239. E-mail:
tynerj@
123456ohsu.edu
Cancer Res 2022;82:1448–60
Author information
Article
Publisher ID:
CAN-21-3695
DOI: 10.1158/0008-5472.CAN-21-3695
PMC ID: 9018544
PubMed ID: 35195258
SO-VID: 4b2e8b9c-e2af-4ef3-990e-2a9f10936854
Copyright © ©2022 The Authors; Published by the American Association for Cancer Research
License:
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs
International 4.0 License.
Funded by:
NCI, DOI http://dx.doi.org/10.13039/100000054;
Award ID: U54 CA224019
Award ID: U54 CA224079
Award ID: U54 CA224081
Award ID: U54 CA224018
Award ID: U54 CA224068
Award ID: U01 CA217885-03S1
Award ID: R01 CA131261-09S2
Award ID: U54 CA224065-02
Award ID: R01 CA207757-03S1
Award ID: R01 CA192844-04S1
Award ID: R37 CA230617-02S1
Award ID: U01 CA223976-03S1
Award ID: P50 CA186786-07S1
Award ID: U01 CA231776-03S1
Award ID: R01 CA175397-07S1
Award ID: U24 CA232979